Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer’s disease
Andreas Giannisis(Stockholm University), Henrietta M. Nielsen(Stockholm University), Kalicharan Patra(Stockholm University), Sigrid Botne Sando(Norwegian University of Science and Technology), Guro Berge(Norwegian University of Science and Technology), Gøril Rolfseng Grøntvedt(St Olav's University Hospital), Geir Bråthen(Norwegian University of Science and Technology), Kim Kultima(Uppsala University), Daniel Twohig(Stockholm University), Asma Al-Grety(Uppsala University), Linda R. White(Norwegian University of Science and Technology), Henrik Carlsson(Uppsala University Hospital), Camilla Lauridsen(Norwegian University of Science and Technology)
Cited by 47
Related Papers
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
|Nature Genetics|2015|332
Glial activation and inflammation along the Alzheimer’s disease continuum
|Journal of Neuroinflammation|2019|282
Faced with inequality: chicken do not have a general dosage compensation of sex-linked genes
|BMC Biology|2007|257
Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease
|Circulation|2015|163